| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.04 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.078 | 0.04 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | 0.068 | 0.04 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.04 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.05 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.078 | 0.05 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.05 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | -0.14 | 0.05 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.05 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.11 | 0.05 |